Histogen Inc. (NASDAQ: HSTO) reported Q1 EPS of ($0.81), $0.59 better than the analyst estimate of ($1.40). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Histogen Inc. (HSTO) click here.